Basic Information
| LncRNA/CircRNA Name | LINC01133 |
| Synonyms | NA |
| Region | GRCh38_1:159961218-159984750 |
| Ensemble | ENSG00000224259 |
| Refseq | NR_038849 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung squamous cell carcinoma |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR, RNAi etc. |
| Sample | NSCLC tissues, cell lines (H1703) |
| Expression Pattern | up-regulated |
| Function Description | Quantitative real-time polymerase chain reaction assay confirmed that LINC01133 was upregulated in LSCC but not in the LAD samples. LSCC patients. LINC01133 may promote invasion of LSCC cell. |
| Pubmed ID | 25908174 |
| Year | 2015 |
| Title | A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival. |
External Links
| Links for LINC01133 | GenBank HGNC NONCODE |
| Links for lung squamous cell carcinoma | OMIM COSMIC |